Arcturus Therapeutics Holdings Inc. (ARCT) vs MapLight Therapeutics, Inc. (MPLT)
A side-by-side comparison of Arcturus Therapeutics Holdings Inc. and MapLight Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARCT
Arcturus Therapeutics Holdings Inc.
$13.29HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT
MPLT
MapLight Therapeutics, Inc.
$9.00HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — ARCT vs MPLT
growth of $100 · dividends reinvested · last 1yARCT +27.0% (+27.0%/yr)MPLT -49.4% (-49.4%/yr)ARCT compounded faster over this window
ARCT MPLT
ARCT vs MPLT: by the numbers
- •MPLT is the larger company ($382M vs $378M market cap).
- •Both run net losses; MPLT's is the smaller (0.00% vs -391.90% net margin).
Metrics side by side
Valuation
| Metric | ARCT | MPLT |
|---|---|---|
| P/S ratio | 15.87 | N/A |
| P/B ratio | 2.20 | 1.10 |
Profitability
| Metric | ARCT | MPLT |
|---|---|---|
| Gross margin | 95.50% | 0.00% |
| Operating margin | -111.51% | 0.00% |
| Net margin | -391.90% | 0.00% |
| ROE | -54.29% | -65.99% |
| ROIC | -54.07% | -69.35% |
Growth (annualized)
| Metric | ARCT | MPLT |
|---|---|---|
| Revenue CAGR (5Y) | 22.30% | N/A |
| Total return CAGR (5Y) | -18.73% | N/A |
Go deeper
Dig into the metrics
Arcturus Therapeutics ROEMapLight Therapeutics ROEArcturus Therapeutics operating marginMapLight Therapeutics operating marginArcturus Therapeutics revenue growthMapLight Therapeutics revenue growthArcturus Therapeutics free cash flowMapLight Therapeutics free cash flow
Arcturus Therapeutics & MapLight Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.